FRIDAY 11th APRIL
08.45 a.m.Opening Ceremony
Fenoglio R., Comandone A., Roccatello D.
09.15 a.m. Lecture
Onconephrology: challenges for optimal care
Roccatello D.
10.00 a.m.Review of onconephrology practice in the United States
Chowdhury R.
10.30 a.m. Cancers, drugs and acute tubulointerstitial injury
Perazella M.
11.00 a.m. Glucarpidase for treatment of high dose methotrexate toxicity
Cosmai L.
11.30 a.m. SGLT2 inhibitors in cancer patients
Simeoni M.
12.00 p.m. Electrolite disturbances in cancer patient
Rashidi A.
12.30 p.m. Nutritional management of CKD patients with cancer
Pezzana A.
13.00 p.m. Break
14.00 p.m. Lecture
Recommendations from ADQI 34: Kidney Assessment and Risk Reduction in Onconephrology
Rosner M.
14.45 p.m. The importance of measured GFR in the uro-oncological scenario: new insights from clinical practice
Trevisani F.
15.15 p.m.Dosing of anticancer therapy in patients with CKD
Floris M.
15.45 p.m. Renal replacement therapies and treatment management in cancer
patients
Pani A.
16.15 p.m. Chemotherapy Dosing and AKI Prevention in Oncological Patients
Lentini P.
16.45 p.m.AKI Associated with Cancer therapies
Kitchlu A.
17.15 p.m. Prevention and treatment of cancer in renal transplant
Alfieri C.
17.45 p.m. Stereotactic ablative body radiotherapy for primary renal cell carcinoma
Ricardi U.
18.15 p.m. Advanced renal cell carcinoma: treatment update
Porta C.
SATURDAY 12th APRIL
08.30 a.m.The state of art of cancer pharmacology with a special focus on
antibody-drug conjugates and bispecific antibodies
Comandone A.
09.15 a.m. Cancer immunotherapy: current challenges and future perspectves in RCC
Sangiolo D.
09.45 a.m.Adjuvant treatment for patients with resected renal cell cancer: state of the art
Di Maio M.
10.15 a.m.How to treat my patients with complication after targeted therapy
Malysko J.
10.45 a.m.Nephrotoxicities of cancer immunotherapies: what do you have to known?
Herrmann S.
11.15 a.m.Drug induced TMA, other aHUS and anti-complement therapy
Fenoglio R.
11.45 a.m.Clinicopathologic conference with expert discussants
Barreca A., Del Vecchio G., Lepori N., Jalal A.
13.00 p.m.Break
14.00 p.m.Lecture
Mechanisms of nephrotoxicity of clone restricted Immunoglobulins
Leung N.
14.45 p.m.Update on Stem Cell Transplant for the Nephrologist
Ballen K.
15.15 p.m.Kidney injury after Hemopoietic Cell Transplantation and cellular
therapies
Renaghan A.
15.45 p.m.Renal complications from lymphomas and leukemia
Cortazzi S.
16.15 p.m.PTLD and renal transplantation
Cecere P.
16.45 p.m.MGRS-associated renal disease and transplantation
Sprangers B.
17.15 p.m.Cast nephropathy: from diagnosis to management
De Simone E.
17.45 p.m.Closing remarks
Fenoglio R., Comandone A., Roccatello D.